NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, wi

Algert Global LLC reduced its position in shares of Colgate-Palmolive Company (NYSE: CL) by 12.0% in

Allstate Corp lessened its position in Colgate-Palmolive Company (NYSE: CL) by 36.5% during the unde

Allworth Financial LP trimmed its holdings in shares of Colgate-Palmolive Company (NYSE: CL) by 14.5

CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while hi

CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but

B. Metzler seel. Sohn and Co. AG trimmed its stake in Colgate-Palmolive Company (NYSE: CL) by 26.5%

Abacus FCF Advisors LLC reduced its position in shares of Colgate-Palmolive Company (NYSE: CL) by 55

CL slips below its 50-day SMA as U.S. softness, competition and rising costs weigh despite solid Q2

Colgate's Q2 revenues rise 4.9% as emerging markets, Europe and Hill's drive growth, but U.S. weakne

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Dividend Kings, companies with at least 50 consecutive years of dividend increases, remain the backb

Investors interested in Consumer Products - Staples stocks are likely familiar with BJ's Wholesale C

Despite cost pressures and spending volatility, CL, KMB, CHD and BJ are using strategic initiatives

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Cahill executed a sale of 4,170 shares on Aug. 6, 2026, realizing ~$389,353 in transaction value. Th

Colgate-Palmolive Company remains rated Hold due to valuation concerns, tepid organic growth, and pe

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises the p

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and low

RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises t

Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperf

Dividend stock investors have an excellent choice with this company.

Organic Sales Growth: Organic sales growth was reported in four of five divisions and three of four

CL's Q2 earnings beat as organic sales, productivity and margin gains offset higher brand investment

Colgate-Palmolive beats Q2 2026 earnings estimates, but North America weakness and tariff headwinds

Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20

Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.99 per share which beat the analyst co

Improvement in market sentiment according to CNN Money Fear and Greed index. Dow Jones gains 600+ po

U.S. stock futures higher, focus on Chevron, Apple, ExxonMobil, Amazon and Colgate-Palmolive earning

Colgate-Palmolive Company (NYSE: CL) to release Q2 earnings on July 31, with analysts predicting EPS

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and

Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and rai

Bernstein analyst Cristian Rios initiates coverage on Colgate-Palmolive (NYSE:CL) with a Market P

Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and r

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and rai

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price targ

RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintai

Colgate warns Middle East conflict is driving up costs and hitting global spending. Get the full bre

Colgate-Palmolive (NYSE:CL) affirms FY2026 sales outlook from $20.790 billion-$21.605 billion to $20

Colgate-Palmolive (NYSE:CL) reported quarterly earnings of $0.97 per share which beat the analyst co

Colgate-Palmolive (CL) will release Q1 earnings on May 1. Analysts expect 94 cents/share, up from 91

U.S. stocks close higher, CAT and GOOGL shares jump 10% after earnings, while META and MSFT shares d

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and